Evidence map›Paper›PMID 26771714›Full record

ArticleCell cycle (Georgetown, Tex.)2016

MMSET is dynamically regulated during cell-cycle progression and promotes normal DNA replication.

Debra L Evans, Haoxing Zhang, Hyoungjun Ham, Huadong Pei, SeungBaek Lee, JungJin Kim, Daniel D Billadeau, Zhenkun Lou

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.Biochimica et biophysica acta. Reviews on cancer · 2019
    Review
  12. Review
  13. MB4-2/MB4-3 transcripts ofOncotarget · 2017
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Debra L Evansa Mayo Graduate School, Biochemistry and Molecular Biology (BMB) Track, Mayo Clinic , Rochester , MN , USA.
Haoxing Zhangb Division of Oncology Research , Department of Oncology, Mayo Clinic , Rochester , MN , USA.
Hyoungjun Hamd Mayo Graduate School, Immunology Track, Mayo Clinic , Rochester , MN , USA.
Huadong Peib Division of Oncology Research , Department of Oncology, Mayo Clinic , Rochester , MN , USA.
SeungBaek Leeb Division of Oncology Research , Department of Oncology, Mayo Clinic , Rochester , MN , USA.
JungJin Kimb Division of Oncology Research , Department of Oncology, Mayo Clinic , Rochester , MN , USA.
Daniel D Billadeaub Division of Oncology Research , Department of Oncology, Mayo Clinic , Rochester , MN , USA.
Zhenkun Loub Division of Oncology Research , Department of Oncology, Mayo Clinic , Rochester , MN , USA.
Mayo Clinic in Arizona · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
Ubiquitination and the DNA Damage Response PathwayR01CA130996 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2008 to 2018
$3.3M
The Role of WSB1 in TumorigenesisR01CA189666 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2014 to 2018
$1.6M
Regultion of p53 DeubiquitinationR01CA148940 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2011 to 2015
$1.6M
The Role of MMSET in DNA damage response and ChemoradioresistanceR01CA151329 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2010 to 2011
$645k
NCI NIH HHS CA130996NCI NIH HHS CA148940NCI NIH HHS CA189666NCI NIH HHS P30 CA015083NCI NIH HHS R01 CA130996NCI NIH HHS R01 CA151329
6 · The paper itself

Abstract

The timely and precise duplication of cellular DNA is essential for maintaining genome integrity and is thus tightly-regulated. During mitosis and G1, the Origin Recognition Complex (ORC) binds to future replication origins, coordinating with multiple factors to load the minichromosome maintenance (MCM) complex onto future replication origins as part of the pre-replication complex (pre-RC). The pre-RC machinery, in turn, remains inactive until the subsequent S phase when it is required for replication fork formation, thereby initiating DNA replication. Multiple myeloma SET domain-containing protein (MMSET, a.k.a. WHSC1, NSD2) is a histone methyltransferase that is frequently overexpressed in aggressive cancers and is essential for normal human development. Several studies have suggested a role for MMSET in cell-cycle regulation; however, whether MMSET is itself regulated during cell-cycle progression has not been examined. In this study, we report that MMSET is degraded during S phase in a cullin-ring ligase 4-Cdt2 (CRL4(Cdt2)) and proteasome-dependent manner. Notably, we also report defects in DNA replication and a decreased association of pre-RC factors with chromatin in MMSET-depleted cells. Taken together, our results suggest a dynamic regulation of MMSET levels throughout the cell cycle, and further characterize the role of MMSET in DNA replication and cell-cycle progression.

Indexed as

Cell CycleCell SurvivalDNA ReplicationHCT116 CellsHeLa CellsHistone-Lysine N-MethyltransferaseHumansRepressor ProteinsHistone-Lysine N-MethyltransferaseNSD2 protein, humanRepressor ProteinsCdt2cell cycleDNA replicationE3 ubiquitin ligaseMMSETproliferating cell nuclear antigen (PCNA)ubiquitin

Identifiers

PMID26771714
PMCPMC4825781
OpenAlexW2249602795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.